Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2013
10/03/2013WO2013145667A1 Organic electroluminescence element
10/03/2013WO2013145666A1 Organic electroluminescent element
10/03/2013WO2013144860A1 A therapeutic agent for treatment of blood vessels
10/03/2013WO2013144737A2 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases
10/03/2013WO2013144231A1 Herbicidal compounds
10/03/2013WO2013144172A1 Novel pyrazolopyrimidines
10/03/2013US20130261151 Azabenzimidazoles as respiratory syncytial virus antiviral agents
10/03/2013US20130261138 Fused heterocyclic indane carboxamide cgrp receptor antagonists
10/03/2013US20130261125 Indazole derivatives useful as erk inhibitors
10/03/2013US20130261117 Compounds and methods for kinase modulation, and indications therefor
10/03/2013US20130261116 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
10/03/2013US20130261104 Methods of use of diazacarbazoles for treating cancer
10/03/2013US20130261102 Heterocyclic compounds and uses thereof
10/03/2013US20130261081 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
10/03/2013US20130259830 Crth2 modulators
10/02/2013EP2644195A1 Immunosuppressant Compounds and Compositions
10/02/2013EP2643323A1 Compounds for treating respiratory syncytial virus infections
10/02/2013EP2643322A1 Salts and crystalline forms of an apoptosis-inducing agent
10/02/2013EP2643321A1 Imidazo [1,2-b]pyridazine and imidazo [4,5-b]pyridine derivatives as jak inhibitors
10/02/2013EP2643320A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
10/02/2013EP2643317A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
10/02/2013EP2643315A1 BENZOXAZEPINES AS INHIBITORS OF P13K/mTOR AND METHODS OF THEIR USE AND MANUFACTURE
10/02/2013EP2643311A1 Bicyclic gpr119 modulators
10/02/2013DE102013205093A1 New substituted tetraheterocyclic compounds useful in optoelectronic or electronic components, preferably e.g. organic light-emitting diodes, organic solar cells, dye-sensitized solar cells, batteries and accumulators, and organic diodes
10/02/2013CN103339131A Pharmaceutical composition comprising pyridone derivatives
10/02/2013CN103339130A Methods of making hiv attachment inhibitor prodrug compound and intermediates
10/02/2013CN103339129A Derivatives of azaindazole or diazaindazole type as medicament
10/02/2013CN103339128A Azaindoles as respiratory syncytial virus antiviral agents
10/02/2013CN103339111A Bicyclic acetyl-CoA carboxylase inhibitors
10/02/2013CN103339108A Protease activated receptor 2 (par2) antagonists
10/02/2013CN103333171A Synthesis method of pyrrole[1,2-a]quinoxaline derivative
10/02/2013CN103333168A Amide compound, and preparation method and application thereof
10/02/2013CN103333167A Novel nitrogen-containing heterocyclic compound and organic electronic device using the same
10/02/2013CN102458402B Nicotinamide compounds useful as kinase modulators
10/02/2013CN101687867B Imidazoquinolines with immuno-modulating properties
10/02/2013CN101679251B (Aza)indole derivative and use thereof for medical purposes
10/02/2013CN101348484B Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, method for the production thereof and doped organic semiconductor material containing these
10/01/2013US8546574 Conglomerates of tenatoprazole potassium salts
10/01/2013US8546573 Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate
10/01/2013US8546430 Thalidomide analogs
10/01/2013US8546424 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/01/2013US8546422 Azaindole derivatives as CRTH2 receptor antagonists
10/01/2013US8546421 Oncogenic-RAS-signal dependent lethal compounds
10/01/2013US8546420 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
10/01/2013US8546417 Fused and spirocycle compounds and the use thereof
10/01/2013US8546405 Anti-viral compounds
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546390 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and AIDS
10/01/2013US8546387 Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
10/01/2013US8546385 Benzoic pyrrolopyridine derivatives
10/01/2013US8546291 Cyclic compound, its metal complex and modified metal complex
10/01/2013CA2732950C Imidazopyridin-2-one derivatives
10/01/2013CA2723545C 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
10/01/2013CA2719876C Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/01/2013CA2605738C Novel azaheterocyclic compounds as kinase inhibitors
10/01/2013CA2529613C Agent for repairing corneal sensitivity containing amide compound
09/2013
09/26/2013WO2013142382A1 Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
09/26/2013WO2013141586A1 Novelpyridopyrimidine derivatives and use thereof
09/26/2013WO2013141097A1 Transparent electrode, electronic device, and organic electroluminescent element
09/26/2013WO2013140419A1 A process for synthesis of chiral 3-substituted tetrahydroquinoline derivatives
09/26/2013WO2013140328A1 Process for the preparation of tetracarboxynaphthalenediimide compounds disubstituted with heteroaryl groups
09/26/2013WO2013140319A1 Crystalline form of a succinate salt
09/26/2013WO2013139987A1 Chemical process for preparing spiroindolones and intermediates thereof
09/26/2013WO2013139882A1 Pyrazolopyridines for treatment of parkinsons disease
09/26/2013WO2013109388A8 1,5-naphthyridine derivatives and melk inhibitors containing the same
09/26/2013WO2013076316A3 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)hetarylcarboxamide compounds and their use as herbicides
09/26/2013WO2012112232A8 METHODS AND COMPOSITIONS FOR TREATING β-THALASSEMIA AND SICKLE CELL DISEASE
09/26/2013US20130253197 Fused bicyclic kinase inhibitors
09/26/2013US20130253196 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
09/26/2013US20130253186 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
09/26/2013US20130253002 Compounds and compositions as tlr activity modulators
09/26/2013US20130253001 Highly soluble salt of pyrroloquinoline quinone and method for producing the same
09/26/2013US20130252993 Tricyclic compound and use thereof
09/26/2013US20130252992 Cyclic n,n'-diarylthiourea - androgen receptor antagonist, anti breast cancer composition and use thereof
09/26/2013US20130252981 Pyrimidine compound and use thereof for pest control
09/26/2013US20130252977 Raf Inhibitor Compounds
09/26/2013US20130252975 Novel rock inhibitors
09/26/2013US20130252968 Alkyl amides as hiv attachment inhibitors
09/26/2013US20130252967 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
09/26/2013US20130252966 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
09/26/2013US20130252952 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
09/26/2013US20130252941 Pyrazolopyridine compounds, compositions and methods of use
09/26/2013US20130252939 Tri-cyclic pyrazolopyridine kinase inhibitors
09/26/2013US20130251647 Low molecular weight modulators of the cold menthol receptor trpm8 and use thereof
09/25/2013EP2640726A1 Novel compound for organic electronic material and organic electroluminescent device using the same
09/25/2013EP2640724A1 Novel indolizine derivatives, and preparation and therapeutic use thereof
09/25/2013EP2640723A1 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
09/25/2013EP2640722A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
09/25/2013EP2640719A2 Antiviral compounds
09/25/2013EP2640705A2 Novel antiviral compounds
09/25/2013EP2640704A1 Nampt inhibitors
09/25/2013EP2640698A1 Nampt and rock inhibitors
09/25/2013EP2640392A2 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
09/25/2013CN103329299A Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
09/25/2013CN103328478A Piperidinone carboxamide azaindane cgrp receptor antagonists
09/25/2013CN103328477A Pharmaceutical composition comprising pyridone derivatives
09/25/2013CN103328476A Optically-active diazabicyclooctane derivative and method for manufacturing same
09/25/2013CN103328475A Compound having pyridoindole ring structure and substituted bipyridyl group, and organic electroluminescent element
09/25/2013CN103328474A Salts and crystalline forms of an apoptosis-inducing agent
09/25/2013CN103328473A Substituted azaindazole compounds
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 646